テトラヒドロピリド[4,3-d]ピリミジノン誘導体およびそれらの使用方法

Title:

テトラヒドロピリド[4,3-d]ピリミジノン誘導体およびそれらの使用方法

Document Type and Number:

Japanese Patent JP2010524944

Kind Code:

A

Abstract:

The present invention relates to methods of using Tetrahydropyrido[4,3-d]Pyrimidinone Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of GPR119 in a patient.

More Like This:

JP2009091339	DRUG FOR TREATING RHEUMATOID ARTHRITIS
WO/2017/197904	NEW CRYSTAL FORMS OF PALBOCICLIB, AND PREPARATION METHOD AND USE THEREFOR
JP2023530768	FGFR and its mutation inhibitor, its production method and application

Inventors:

Boyle, Craig Dee.
Neustadt, Bernard Earl.

Application Number:

JP2010504089A

Publication Date:

July 22, 2010

Filing Date:

April 17, 2008

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Schering Corporation

International Classes:

A61K31/519; A61K45/00; A61P3/04; A61P3/06; A61P3/10; A61P9/10; A61P9/12; A61P43/00; C07D471/04

Attorney, Agent or Firm:

Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita

Previous Patent: ケラチンバイオマテリアルを含有する創傷治癒組成物

Next Patent: タンパク質で修飾されたナノ液滴、ならびにその合成物および製造方法